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patients. For pLDH, in children under 5 years, NPV ranged from a peak of 
98.9% at a low-transmission site, to just 49.0% at a high-transmission 
site; in patients aged 5 years and older, the NPV fell from 98.1% to 
69.3%. The NPV of expert microscopy was very similar to that of pLDH 
across all sites and age ranges. In conclusion, considering diagnosis based 
on PCR as a gold standard, microscopy or pLDH are likely to provide 
the best diagnostic utility at sites with low transmission, while HRP2 is 
recommended for medium- and high-transmission areas.
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We evaluated a new pLDH malaria rapid diagnostic test (First Response 
Malaria Pf/Pv Antigen Strips by Premier Medical Corporation Ltd, India) as 
a potential screening tool for Plasmodium falciparum (Pf) and P. vivax (Pv) 
infection in pregnant women attending for antenatal care. Two 6 week 
cross-sectional surveys were conducted in 3 districts in Central India, one 
in the dry hot season (March-April) and one post monsoon (October-
November), the later representing the peak prevalence of P. vivax and P. 
falciparum, respectively. Overall, 1812 pregnant women (815 in the dry 
season and 997 in the post-monsoon survey) attending routine antenatal 
care were screened for malaria with the RDT and conventional light 
microscopy, irrespective of clinical symptoms. Based on microscopy, the 
prevalence of Pf and Pv was 0.8% and 1.2% in the dry season and 5.7% 
and 0.7% post-monsoon season, respectively, with marked variations 
of Pf prevalence between the 3 sites in the latter survey (0%, 2.7% and 
18.1%). The overall geometric mean parasite densities (GMPDs) of Pf 
(n=62) and Pv (n=16) infections were 1380 (95% CI 795-2395) and 908 
(95% CI 449-1838), respectively. The GMPDs for P. vivax were significantly 
lower in the dry season survey than the post monsoon survey (422 vs 
2434). Using microscopy as the gold standard, the overall sensitivity and 
specificity of the RDT test were 95.2% and 99.6% for Pf and 68.8% and 
99.4% for Pv, respectively. The positive and negative predictive values 
were 90.8% and 99.8% for Pf, respectively, and 52.4% and 99.7% for 
Pv. Four out of 7 P. falciparum infections with densities <250 parasites/ul 
were detected by RDT, but this was 1 of 5 for Pv. Confirmation using 
PCR is ongoing. The First Response Pf/Pv antigen strips test was easy to 
learn and is a potential alternative to microscopy where the facilities for 
microscopy are poor or non existent. It was highly sensitive and specific in 
the screening of mainly asymptomatic pregnant women for P. falciparum 
infection, but was less accurate as screening test for low density P. vivax 
infections.
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Rapid diagnostic tests (RDTs) represent an alternative to microscopy for 
malaria diagnosis and have shown high sensitivity and specificity in a 
variety of study settings. Current WHO guidelines for quality control of 
RDTs provide detailed instructions on pre-field testing, but offer little 
guidance for quality assurance once RDTs are deployed in health facilities. 
From September 2006 to April 2007, we introduced HRP2-based RDTs 
(Paracheck Pf) for suspected malaria cases in 9 health facilities with 
existing microscopy services in Rufiji District, Tanzania. Rufiji District is a 
rural setting with holoendemic malaria transmission. Thick blood smears 
were collected for all patients tested with RDTs and stained and read by 
laboratory personnel in each facility. Thick smears were subsequently 
reviewed by a reference microscopist to determine RDT sensitivity and 
specificity. In all 9 health facilities there were significant problems with 
the quality of staining and microscopy. Intensive refresher training did 
not result in substantial improvements in the quality of slide preparation. 
Sensitivity and specificity of RDTs were difficult to assess given the poor 
quality of routine blood smear staining. Mean operational sensitivity of 
RDTs based upon reference microscopy was 64.8%, but varied greatly 
by health facility, range 18.8-85.9%. Sensitivity of RDTs increased with 
increasing parasite density. Specificity remained high at 87.8% despite 
relatively poor slide quality. Institution of quality control of RDTs based on 
poor quality blood smear staining may impede reliable measurement of 
sensitivity and specificity and undermine confidence in the new diagnostic. 
Reliable staining and microscopy for quality control must be a prerequisite 
to the introduction of RDTs.
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With the increasing variety of RDTs on the market, policy makers must 
identify the most appropriate test, and circumstances where presumptive 
treatment remains the preferred strategy. This choice is likely to vary 
widely not only in response to test characteristics but also to characteristics 
of the population where RDTs are to be deployed. An economic model 
was developed as a decision aid, adaptable to different scenarios of ACT 
and RDT costs, and test accuracies. The model also enables the user to 
vary estimates for other factors, such as the potential harm of treatment, 
including risk of adverse events and drug resistance, and the probability 
that clinicians will adhere to test results. In a recent trial the accuracy of 
two RDTs (detecting either pLDH or HRP2 antigens) was evaluated in 7 
sites across Uganda. The data on costs and accuracies were entered into 
the model to illustrate its use and results. Output was then obtained at 
increasing levels of comprehensiveness, starting with direct expenditure 
on diagnostics and treatment alone, and then introducing patient health 
outcomes, compromised adherence with test results, and the broader 
societal costs associated with overprescription of antimalarials. Results 
suggest that given current RDT and ACT prices, use of the HRP2 RDT 
would be justifiable across most prevalences and age groups. This 
however depends to a great extent on whether factors such as the harm 
associated with use of antimalarials and the probability clinicians adhere 
to results is included in the analysis. Excluding the harm of treatment, 
presumptive treatment is justified for younger children, and the benefit 
in the use of RDTs for older patients is also limited. Results also indicate 
to the need to ensure that clinicians adhere to negative test result if RDTs 
are to remain an efficient use of resources. Results are expected to vary 
widely by location and over time as prices and effectiveness of RDTs and 
ACTs change, therefore the model was designed for easy incorporation of 
local and up to date parameter estimates for identification to support local 
decision making.
